The Gates Vascular Institute and the University at Buffalo‘s Clinical and Translational Research Center is a 10 story building at 875 Ellicott St, Buffalo, New York. The Institute is next to Buffalo General Medical Center and opened on May 24, 2012.

During the past decade, Gates Vascular Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Gates Vascular Institute" are "Coronary Artery Disease" (1 trials), "Ischemic Heart Disease" (1 trials), "Pulmonary Embolism" (1 trials) and "Pulmonary Thrombo-embolism" (1 trials). Many other conditions were trialed in "Gates Vascular Institute" in a lesser frequency.

Most popular intervention types in "Gates Vascular Institute" are "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Catheter-Directed Thrombolysis" (1 trials), "FlowTriever System" (1 trials), "Philips SyncVision system with Philips pressure wires" (1 trials) and "standard of care angiographically-guided PCI" (1 trials). Other intervention names were less common.

The vast majority of trials in "Gates Vascular Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Gates Vascular Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Gates Vascular Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Gates Vascular Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".